Central nervous system cancers

Louis Burt Nabors, Mario Ammirati, Philip Jay Bierman, Henry Brem, Nicholas Butowski, Marc C. Chamberlain, Lisa M. DeAngelis, Robert A. Fenstermaker, Allan Friedman, Mark R. Gilbert, Deneen Hesser, Matthias Holdhoff, Larry Junck, Ronald Lawson, Jay S. Loeffler, Moshe H. Maor, Paul L. Moots, Tara Morrison, Maciej M. Mrugala, Herbert B. Newton & 10 others Jana Portnow, Jeffrey J. Raizer, Lawrence Recht, Dennis C. Shrieve, Allen K. Sills, David Tran, Nam Tran, Frank D. Vrionis, Patrick Y. Wen, Maria Ho

Research output: Contribution to journalReview article

28 Citations (Scopus)

Abstract

Primary and metastatic tumors of the central nervous system are a heterogeneous group of neoplasms with varied outcomes and management strategies. Recently, improved survival observed in 2 randomized clinical trials established combined chemotherapy and radiation as the new standard for treating patients with pure or mixed anaplastic oligodendroglioma harboring the 1p/19q codeletion. For metastatic disease, increasing evidence supports the efficacy of stereotactic radiosurgery in treating patients with multiple metastatic lesions but low overall tumor volume. These guidelines provide recommendations on the diagnosis and management of this group of diseases based on clinical evidence and panel consensus. This version includes expert advice on the management of low-grade infiltrative astrocytomas, oligodendrogliomas, anaplastic gliomas, glioblastomas, medulloblastomas, supratentorial primitive neuroectodermal tumors, and brain metastases. The full online version, available at NCCN. org, contains recommendations on additional subtypes.

Original languageEnglish (US)
Pages (from-to)1114-1151
Number of pages38
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume11
Issue number9
StatePublished - Sep 1 2013

Fingerprint

Oligodendroglioma
Central Nervous System
Primitive Neuroectodermal Tumors
Central Nervous System Neoplasms
Medulloblastoma
Radiosurgery
Astrocytoma
Glioblastoma
Disease Management
Tumor Burden
Glioma
Neoplasms
Randomized Controlled Trials
Guidelines
Radiation
Neoplasm Metastasis
Drug Therapy
Survival
Brain

ASJC Scopus subject areas

  • Oncology

Cite this

Burt Nabors, L., Ammirati, M., Bierman, P. J., Brem, H., Butowski, N., Chamberlain, M. C., ... Ho, M. (2013). Central nervous system cancers. JNCCN Journal of the National Comprehensive Cancer Network, 11(9), 1114-1151.

Central nervous system cancers. / Burt Nabors, Louis; Ammirati, Mario; Bierman, Philip Jay; Brem, Henry; Butowski, Nicholas; Chamberlain, Marc C.; DeAngelis, Lisa M.; Fenstermaker, Robert A.; Friedman, Allan; Gilbert, Mark R.; Hesser, Deneen; Holdhoff, Matthias; Junck, Larry; Lawson, Ronald; Loeffler, Jay S.; Maor, Moshe H.; Moots, Paul L.; Morrison, Tara; Mrugala, Maciej M.; Newton, Herbert B.; Portnow, Jana; Raizer, Jeffrey J.; Recht, Lawrence; Shrieve, Dennis C.; Sills, Allen K.; Tran, David; Tran, Nam; Vrionis, Frank D.; Wen, Patrick Y.; Ho, Maria.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 11, No. 9, 01.09.2013, p. 1114-1151.

Research output: Contribution to journalReview article

Burt Nabors, L, Ammirati, M, Bierman, PJ, Brem, H, Butowski, N, Chamberlain, MC, DeAngelis, LM, Fenstermaker, RA, Friedman, A, Gilbert, MR, Hesser, D, Holdhoff, M, Junck, L, Lawson, R, Loeffler, JS, Maor, MH, Moots, PL, Morrison, T, Mrugala, MM, Newton, HB, Portnow, J, Raizer, JJ, Recht, L, Shrieve, DC, Sills, AK, Tran, D, Tran, N, Vrionis, FD, Wen, PY & Ho, M 2013, 'Central nervous system cancers', JNCCN Journal of the National Comprehensive Cancer Network, vol. 11, no. 9, pp. 1114-1151.
Burt Nabors L, Ammirati M, Bierman PJ, Brem H, Butowski N, Chamberlain MC et al. Central nervous system cancers. JNCCN Journal of the National Comprehensive Cancer Network. 2013 Sep 1;11(9):1114-1151.
Burt Nabors, Louis ; Ammirati, Mario ; Bierman, Philip Jay ; Brem, Henry ; Butowski, Nicholas ; Chamberlain, Marc C. ; DeAngelis, Lisa M. ; Fenstermaker, Robert A. ; Friedman, Allan ; Gilbert, Mark R. ; Hesser, Deneen ; Holdhoff, Matthias ; Junck, Larry ; Lawson, Ronald ; Loeffler, Jay S. ; Maor, Moshe H. ; Moots, Paul L. ; Morrison, Tara ; Mrugala, Maciej M. ; Newton, Herbert B. ; Portnow, Jana ; Raizer, Jeffrey J. ; Recht, Lawrence ; Shrieve, Dennis C. ; Sills, Allen K. ; Tran, David ; Tran, Nam ; Vrionis, Frank D. ; Wen, Patrick Y. ; Ho, Maria. / Central nervous system cancers. In: JNCCN Journal of the National Comprehensive Cancer Network. 2013 ; Vol. 11, No. 9. pp. 1114-1151.
@article{7e05e95930e64dbc940284a3cc04657c,
title = "Central nervous system cancers",
abstract = "Primary and metastatic tumors of the central nervous system are a heterogeneous group of neoplasms with varied outcomes and management strategies. Recently, improved survival observed in 2 randomized clinical trials established combined chemotherapy and radiation as the new standard for treating patients with pure or mixed anaplastic oligodendroglioma harboring the 1p/19q codeletion. For metastatic disease, increasing evidence supports the efficacy of stereotactic radiosurgery in treating patients with multiple metastatic lesions but low overall tumor volume. These guidelines provide recommendations on the diagnosis and management of this group of diseases based on clinical evidence and panel consensus. This version includes expert advice on the management of low-grade infiltrative astrocytomas, oligodendrogliomas, anaplastic gliomas, glioblastomas, medulloblastomas, supratentorial primitive neuroectodermal tumors, and brain metastases. The full online version, available at NCCN. org, contains recommendations on additional subtypes.",
author = "{Burt Nabors}, Louis and Mario Ammirati and Bierman, {Philip Jay} and Henry Brem and Nicholas Butowski and Chamberlain, {Marc C.} and DeAngelis, {Lisa M.} and Fenstermaker, {Robert A.} and Allan Friedman and Gilbert, {Mark R.} and Deneen Hesser and Matthias Holdhoff and Larry Junck and Ronald Lawson and Loeffler, {Jay S.} and Maor, {Moshe H.} and Moots, {Paul L.} and Tara Morrison and Mrugala, {Maciej M.} and Newton, {Herbert B.} and Jana Portnow and Raizer, {Jeffrey J.} and Lawrence Recht and Shrieve, {Dennis C.} and Sills, {Allen K.} and David Tran and Nam Tran and Vrionis, {Frank D.} and Wen, {Patrick Y.} and Maria Ho",
year = "2013",
month = "9",
day = "1",
language = "English (US)",
volume = "11",
pages = "1114--1151",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "9",

}

TY - JOUR

T1 - Central nervous system cancers

AU - Burt Nabors, Louis

AU - Ammirati, Mario

AU - Bierman, Philip Jay

AU - Brem, Henry

AU - Butowski, Nicholas

AU - Chamberlain, Marc C.

AU - DeAngelis, Lisa M.

AU - Fenstermaker, Robert A.

AU - Friedman, Allan

AU - Gilbert, Mark R.

AU - Hesser, Deneen

AU - Holdhoff, Matthias

AU - Junck, Larry

AU - Lawson, Ronald

AU - Loeffler, Jay S.

AU - Maor, Moshe H.

AU - Moots, Paul L.

AU - Morrison, Tara

AU - Mrugala, Maciej M.

AU - Newton, Herbert B.

AU - Portnow, Jana

AU - Raizer, Jeffrey J.

AU - Recht, Lawrence

AU - Shrieve, Dennis C.

AU - Sills, Allen K.

AU - Tran, David

AU - Tran, Nam

AU - Vrionis, Frank D.

AU - Wen, Patrick Y.

AU - Ho, Maria

PY - 2013/9/1

Y1 - 2013/9/1

N2 - Primary and metastatic tumors of the central nervous system are a heterogeneous group of neoplasms with varied outcomes and management strategies. Recently, improved survival observed in 2 randomized clinical trials established combined chemotherapy and radiation as the new standard for treating patients with pure or mixed anaplastic oligodendroglioma harboring the 1p/19q codeletion. For metastatic disease, increasing evidence supports the efficacy of stereotactic radiosurgery in treating patients with multiple metastatic lesions but low overall tumor volume. These guidelines provide recommendations on the diagnosis and management of this group of diseases based on clinical evidence and panel consensus. This version includes expert advice on the management of low-grade infiltrative astrocytomas, oligodendrogliomas, anaplastic gliomas, glioblastomas, medulloblastomas, supratentorial primitive neuroectodermal tumors, and brain metastases. The full online version, available at NCCN. org, contains recommendations on additional subtypes.

AB - Primary and metastatic tumors of the central nervous system are a heterogeneous group of neoplasms with varied outcomes and management strategies. Recently, improved survival observed in 2 randomized clinical trials established combined chemotherapy and radiation as the new standard for treating patients with pure or mixed anaplastic oligodendroglioma harboring the 1p/19q codeletion. For metastatic disease, increasing evidence supports the efficacy of stereotactic radiosurgery in treating patients with multiple metastatic lesions but low overall tumor volume. These guidelines provide recommendations on the diagnosis and management of this group of diseases based on clinical evidence and panel consensus. This version includes expert advice on the management of low-grade infiltrative astrocytomas, oligodendrogliomas, anaplastic gliomas, glioblastomas, medulloblastomas, supratentorial primitive neuroectodermal tumors, and brain metastases. The full online version, available at NCCN. org, contains recommendations on additional subtypes.

UR - http://www.scopus.com/inward/record.url?scp=84885093316&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885093316&partnerID=8YFLogxK

M3 - Review article

VL - 11

SP - 1114

EP - 1151

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 9

ER -